News for Lupin Limited (LUPIN.BO)

Lupin's shares increased by 21.51% over the past year. However, year-to-date (YTD), the stock has decreased by 14.21%. Over the last six months, the price fell by 10.12%, while in the past three months, it dropped by 4.86%. In the last month, the price declined by 7.76%.

Stocks including JSW Steel, Coal India, ONGC, Tata Power, RailTel, BHEL, Concor, Lupin, Biocon, GMR Airports and IRB Infra will be in the spotlight on Monday, March 10.

The Nifty Pharma index closed 0.22 per cent down at 20378.3.

The Nifty Pharma index was trading 0.8 per cent up at 19978.6.

The Nifty Pharma index was trading 0.33 per cent down at 19814.9.

The Nifty Pharma index closed 0.33 per cent up at 19879.8.

The Nifty Pharma index was trading 0.64 per cent down at 19687.35.

Several brokerages have upgraded the target prices of various stocks over the past month. According to Trendlyne data, 10 BSE midcap index stocks, Coforge, Persistent Systems, Lupin, Aurobindo Pharma, Muthoot Finance, and United Breweries have received up to four analysts' target price upgrades in the last month. Here is a list of these stocks: Target Price Upgrades

The Nifty Pharma index closed 1.92 per cent down at 19813.5.

Industry insiders in India warn that any such move in the pharmaceutical sector could be counterproductive for the US as it may face increased drug shortages if tariffs are imposed on such imports.

The Nifty Pharma index was trading 0.61 per cent down at 20125.55.

The Nifty Pharma index was trading 0.13 per cent down at 20362.85.

Stocks including Quality Power, Bajaj Auto, Zomato, Jio Financial, Swiggy, RVNL, Vedanta, Adani Green, Lupin, Coal India will be in the spotlight on Monday, February 24.

The Nifty Pharma index closed 1.92 per cent down at 20385.65.

The Nifty Pharma index was trading 0.17 per cent down at 20783.9.

Indian markets have witnessed a sharp correction over the last five months owing to multiple macro reasons and a cut in overall earnings expectations. Out of the 5,684 stocks listed on the BSE, 3,446 stocks have declined in the last five months, while from the NSE Nifty 500, 458 stocks have declined in the same period. However, it appears that there are multiple stocks that have been weighed down much more owing to macro reasons as these have actually seen earnings upgrade.

The Nifty Pharma index closed 0.71 per cent down at 20820.0.

The Nifty Pharma index was trading 0.67 per cent down at 20828.3.

Amid the ongoing selling on Dalal Street, the benchmark equity index has plunged nearly 10% since October 2024.